RIFAPENTINE, 150mg, disp. tab., blister
NST
DORARIFP1TD1
Valid Article
HS Code:
300420
Last Updated on:
07/11/2024, 20:35:49
6.2.5 - Antituberculosis medicines
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
J04AB05
Anatomical Therapeutic Chemical Classification according to WHOCC
OC subscriptions: included in supply or field order tools (e.g. UniField)
|
|
SC subscriptions: included in supply or field tools
|
|
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
|
|
RIFAPENTINE
Therapeutic Action
Rifamycin, bactericidal
Indications
Latent Tuberculosis Infection (LTI-TB)
Instructions for use
Tablets can be crushed and mixed into a spoon with a small amount of food.
The 150 mg tablet is intended for children below 14 years.
Must be taken with food.
For children over 14 years of age and adults, when rifapentine is used in combination with isoniazid, a fixed-dose combination (FDC) is available: ISONIAZID 300mg / RIFAPENTINE, 300mg, tab., blister.
Blister packaging is the packaging of choice for antituberculosis medicines due to the unstable nature of some of them when exposed to higher temperatures and humidity.
The quantity to be ordered is calculated per tablet, not per blister.
Storage
Below 25°C - Protect from sunlight, Protect from humidity